We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.13 | 0.12 | 0.14 | 0.13 | 0.13 | 0.13 | 100,000 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
From Apr 2019 to Apr 2024
TIDMDEMG
RNS Number : 4490E
Deltex Medical Group PLC
09 February 2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, RUSSIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
9 February 2018
Deltex Medical Group plc
("Deltex" or the "Company")
Result of Offer and Additional Allotment
On 24 January 2018, the Company published its shareholder circular (the "Circular") in connection with the Capital Raising including details of the Offer to raise GBP350,000.
Result of the Offer and Additional Allotment
The Offer closed for acceptances at 12.00 noon. on 7 February 2018.
The Company announces that valid acceptances have been received from Qualifying Participants in respect of 61,015,191 Offer Shares. This represents approximately 218 per cent. of the maximum number of Offer Shares available under the Offer.
The Company has therefore raised the maximum gross proceeds of GBP350,000 through the Offer. This is in addition to the GBP1.75 million (before expenses) to be raised pursuant to the Placing and the Subscription.
The Directors have considered the high level of interest from existing shareholders in the Offer and have decided to allot to certain existing shareholders a further 8,650,000 Ordinary Shares (the "Additional Shares) using the allotment authorities granted to the Directors at the annual general meeting of the Company on 9 June 2017. This has the effect of reducing the level of scale back of applications under the Offer from 54 per cent. to 40 per cent. and accordingly allows Qualifying Participants to receive a greater proportion of the Ordinary Shares under the Offer than would otherwise have been the case.
Qualifying Participants have been scaled back across the Offer and the Additional Shares (taken together) pro rata to the number of Offer Shares applied for by Qualifying Participants. Those who applied by cheque will receive refund cheques for those shares not allotted under their application in due course.
Offer Shares and Additional Shares (held in uncertificated form) are expected to be credited to CREST accounts on 12 February 2018 and definitive share certificates for the Offer Shares and Additional Shares (held in certificated form) are expected to be despatched to shareholders who hold their Ordinary Shares in certificated form by 23 February 2018.
The Capital Raising (as enlarged by the Additional Shares) remains conditional upon, amongst other things, Shareholder approval of the Resolution at the General Meeting to be at 10.00 a.m. on 9 February 2018 and Admission.
It is expected that the Admission of the 28,000,000 Offer Shares and the Additional Shares will become effective at 8.00 a.m. on 12 February 2018.
Directors Participation
As disclosed in the Circular certain Directors indicated their intention to subscribe in the Offer. The Company confirms that the following five Directors participated in the Offer (as augmented by the Additional Shares), pari passu, with other applicants under the Offer (as so augmented):
Hot Features
Premium
Ordinary Offer Ordinary % of
Shares Shares Shares the Company's
held before applied Ordinary held post Enlarged
the Capital for under Scale Shares the Capital Share
Director Raising the Offer back allotted Raising Capital
--------------- ------------- ----------- ------ ---------- ------------- ---------------
Ewan Phillips 2,921,051 1,600,000 40% 961,060 3,882,111 0.8%
--------------- ------------- ----------- ------ ---------- ------------- ---------------
Jonathan
Shaw 262,931 400,000 40% 240,265 503,196 0.1%
--------------- ------------- ----------- ------ ---------- ------------- ---------------
Julian
Cazalet 7,063,020 2,400,000 40% 1,442,050 8,505,070 1.7%
--------------- ------------- ----------- ------ ---------- ------------- ---------------
Mark Wippell 1,108,444 800,000 40% 480,530 1,588,974 0.3%
--------------- ------------- ----------- ------ ---------- ------------- ---------------
Sir Duncan
Nichol 1,586,912 1,200,000 40% 720,795 2,307,707 0.5%
--------------- ------------- ----------- ------ ---------- ------------- ---------------
The issue of Ordinary Shares to the five Directors, listed in the table above, is considered to be a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. The independent Directors (considered to be Nigel Keen and Christopher Jones) consider, having consulted with Arden Partners plc, the Company's nominated adviser, that the terms of the issue of Ordinary Shares to the five Directors noted above are fair and reasonable in so far as the Company's Shareholders are concerned.
Capitalised terms used in this announcement shall have the same meanings given to them in the Circular.
Ewan Phillips, Chief Executive of Deltex, said:
"The Company is pleased that the Offer to its existing shareholders was substantially oversubscribed and that it was able to reduce the level of subsequent scale back by the allotment of additional shares. The additional proceeds will be applied for general working capital purposes."
For further information please contact:
Deltex Medical Ewan Phillips 01243 774 837
Group plc Jonathan Shaw investorinfo@deltexmedical.com
Arden Partners Chris Hardie
plc Ciaran Walsh 020 7614 5900
Turner Pope Investments Andy Thacker 0203 621 4120
(TPI) Ltd info@turnerpope.com
Tim Metcalfe
Graham Herring
IFC Advisory Ltd Heather Armstrong 0203 934 6630
PDMR Notification Forms:
The notifications below are made in accordance with the requirements of MAR.
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Ewan Phillips
--- ------------------------------- ---------------------------
2. Reason for the Notification
--- ------------------------------------------------------------
a) Position/status Chief Executive
--- ------------------------------- ---------------------------
b) Initial notification/amendment Initial notification
--- ------------------------------- ---------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Deltex Medical Group plc
--- ------------------------------- ---------------------------
b) LEI N/A
--- ------------------------------- ---------------------------
4. Details of the transaction(s):section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv)each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence
the Financial instrument, each
type of instrument
--- ------------------------------- ---------------------------
Identification GB00B95L0551
code
--- ------------------------------- ---------------------------
b) Nature of the Transaction Subscription of ordinary
shares
--- ------------------------------- ---------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
1.25p 961,060
--------- ----------
--- ------------------------------- ---------------------------
d) Aggregated information N/A (Single transaction)
Aggregated volume
Price
--- ------------------------------- ---------------------------
e) Date of the transaction 12 February 2018
--- ------------------------------- ---------------------------
f) Place of the transaction London Stock Exchange, AIM
--- ------------------------------- ---------------------------
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Jonathan Shaw
--- ------------------------------- ---------------------------
2. Reason for the Notification
--- ------------------------------------------------------------
a) Position/status Finance Director
--- ------------------------------- ---------------------------
b) Initial notification/amendment Initial notification
--- ------------------------------- ---------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Deltex Medical Group plc
--- ------------------------------- ---------------------------
b) LEI N/A
--- ------------------------------- ---------------------------
4. Details of the transaction(s):section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv)each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence
the Financial instrument, each
type of instrument
--- ------------------------------- ---------------------------
Identification GB00B95L0551
code
--- ------------------------------- ---------------------------
b) Nature of the Transaction Subscription of ordinary
shares
--- ------------------------------- ---------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
1.25p 240,265
--------- ----------
--- ------------------------------- ---------------------------
d) Aggregated information N/A (Single transaction)
Aggregated volume
Price
--- ------------------------------- ---------------------------
e) Date of the transaction 12 February 2018
--- ------------------------------- ---------------------------
f) Place of the transaction London Stock Exchange, AIM
--- ------------------------------- ---------------------------
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Julian Cazalet
--- ------------------------------- ---------------------------
2. Reason for the Notification
--- ------------------------------------------------------------
a) Position/status Non-executive Director
--- ------------------------------- ---------------------------
b) Initial notification/amendment Initial notification
--- ------------------------------- ---------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Deltex Medical Group plc
--- ------------------------------- ---------------------------
b) LEI N/A
--- ------------------------------- ---------------------------
4. Details of the transaction(s):section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv)each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence
the Financial instrument, each
type of instrument
--- ------------------------------- ---------------------------
Identification GB00B95L0551
code
--- ------------------------------- ---------------------------
b) Nature of the Transaction Subscription of ordinary
shares
--- ------------------------------- ---------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
1.25p 1,442,050
--------- ----------
--- ------------------------------- ---------------------------
d) Aggregated information N/A (Single transaction)
Aggregated volume
Price
--- ------------------------------- ---------------------------
e) Date of the transaction 12 February 2018
--- ------------------------------- ---------------------------
f) Place of the transaction London Stock Exchange, AIM
--- ------------------------------- ---------------------------
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Mark Wippell
--- ------------------------------- ---------------------------
2. Reason for the Notification
--- ------------------------------------------------------------
a) Position/status Non-executive Director
--- ------------------------------- ---------------------------
b) Initial notification/amendment Initial notification
--- ------------------------------- ---------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Deltex Medical Group plc
--- ------------------------------- ---------------------------
b) LEI N/A
--- ------------------------------- ---------------------------
4. Details of the transaction(s):section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv)each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence
the Financial instrument, each
type of instrument
--- ------------------------------- ---------------------------
Identification GB00B95L0551
code
--- ------------------------------- ---------------------------
b) Nature of the Transaction Subscription of ordinary
shares
--- ------------------------------- ---------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
1.25p 480,530
--------- ----------
--- ------------------------------- ---------------------------
d) Aggregated information N/A (Single transaction)
Aggregated volume
Price
--- ------------------------------- ---------------------------
e) Date of the transaction 12 February 2018
--- ------------------------------- ---------------------------
f) Place of the transaction London Stock Exchange, AIM
--- ------------------------------- ---------------------------
1. Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Sir Duncan Nichol
--- ------------------------------- ---------------------------
2. Reason for the Notification
--- ------------------------------------------------------------
a) Position/status Non-executive Director
--- ------------------------------- ---------------------------
b) Initial notification/amendment Initial notification
--- ------------------------------- ---------------------------
3. Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Deltex Medical Group plc
--- ------------------------------- ---------------------------
b) LEI N/A
--- ------------------------------- ---------------------------
4. Details of the transaction(s):section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv)each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 1 pence
the Financial instrument, each
type of instrument
--- ------------------------------- ---------------------------
Identification GB00B95L0551
code
--- ------------------------------- ---------------------------
b) Nature of the Transaction Subscription of ordinary
shares
--- ------------------------------- ---------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
1.25p 720,795
--------- ----------
--- ------------------------------- ---------------------------
d) Aggregated information N/A (Single transaction)
Aggregated volume
Price
--- ------------------------------- ---------------------------
e) Date of the transaction 12 February 2018
--- ------------------------------- ---------------------------
f) Place of the transaction London Stock Exchange, AIM
--- ------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUGUGGPUPRGUB
(END) Dow Jones Newswires
February 09, 2018 05:12 ET (10:12 GMT)
1 Year Deltex Medical Chart |
1 Month Deltex Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
